During a meeting with the Deputy for Human Development, Minister of Health Khaled Abdel Ghaffar, and the Egyptian Medicines Authority Chairman Ali Al-Ghamrawi, Egypt’s Prime Minister Mostafa Madbouly issued directives to address the shortage of medicine in the country.
Prime Minister Mostafa Madbouly convened a meeting yesterday to oversee the ongoing efforts to address medication shortages and ensure the availability of essential medicines.
The meeting was attended by Dr. Khaled Abdel Ghaffar, the Deputy Prime Minister for Human Development and the Minister of Health and Population, as well as Dr. Ali Al-Ghamrawi, the Chairman of the Egyptian Medicines Authority.
“According to a statement released by the Cabinet on Sunday, we have received several complaints. It is imperative that we address these issues and collaborate with pharmaceutical companies to increase production. We are fully prepared to assist in any necessary measures.”
During the meeting, the Minister of Health expressed that the current crisis stemmed from a shortage of dollar liquidity. This scarcity has had adverse effects on the operations of pharmaceutical manufacturing companies and subsequently impacted the availability of medicines in the markets. Abdel-Ghaffar affirmed that the crisis is beginning to alleviate with the improved availability of dollar liquidity. He provided reassurance that the issue would be resolved in the coming weeks.
During the presentation, the head of the Drug Authority provided a comprehensive overview of the organization’s initiatives to ensure the availability of essential medications in the market, aligned with specified priorities.
Additionally, he outlined the Authority’s strategy for maintaining a strategic supply of drugs and preparations for various purposes. Moreover, he addressed the mechanisms for monitoring medication inventory, regulating the diverse supply and distribution networks, and the endeavors to bolster pharmaceutical production to meet local demand.
